ArticleEJHaem2026

Targeting CD162 for Life-Threatening Cutaneous Chronic Graft-Versus-Host Disease: A Case Report.

Alicia Lieberman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.